CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 30, 2003--Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live by Merrill Lynch on Tuesday, February 4, 2003 at 4:10pm EST from the Grand Hyatt Hotel in New York. The presentation may be accessed under the investor relations tab at www.alkermes.com and will be archived for 14 days.
Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(R) pulmonary technology. In addition to the headquarters and research and manufacturing facilities in Cambridge, Massachusetts, the company has a manufacturing facility in Chelsea, Massachusetts and a research and manufacturing facility in Ohio.
| CONTACT: | Alkermes, Inc. |
|---|---|
| Rebecca Peterson, 617/583-6378 | |